Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Equillium (0FY) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:0FYEquilliumEUR 1.21EUR 96.34M-7.3258.55%Strong BuyUnlock the DE:0FY analyst price target with TipRanks PremiumDE:0FYUnlock the DE:0FY top-analyst price target with TipRanks Premium
NRXPNRX Pharmaceuticals$2.19$95.59M-2.95-15.44%Strong BuyUnlock the NRXP analyst price target with TipRanks PremiumDE:0FY vs NRXPUnlock the NRXP top-analyst price target with TipRanks Premium
STROSutro Biopharma$9.82$163.03M-0.785.71%Strong BuyUnlock the STRO analyst price target with TipRanks PremiumDE:0FY vs STROUnlock the STRO top-analyst price target with TipRanks Premium
HYFTMindWalk Holdings$0.99$47.10M-3.87-40.00%Strong BuyUnlock the HYFT analyst price target with TipRanks PremiumDE:0FY vs HYFTUnlock the HYFT top-analyst price target with TipRanks Premium
PRLDPrelude Therapeutics$3.45$275.32M-4.37128.48%Moderate BuyUnlock the PRLD analyst price target with TipRanks PremiumDE:0FY vs PRLDUnlock the PRLD top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:0FYEquillium1.210.5071.65%
NRXPNRX Pharmaceuticals2.190.083.79%
STROSutro Biopharma9.821.3215.53%
HYFTMindWalk Holdings0.99-0.73-42.44%
PRLDPrelude Therapeutics3.451.80109.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts